The expression profile of the APOE gene was decreased by ∼0.66-fold in AF without the MetS group and by ∼1.59-fold in AF with the MetS group as compared to an increase by ∼3.41-fold in the control group, representing a significant difference (Table 1). This evidence concerns the gene APOE and metabolic syndrome.